Pfizer (PFE)/BioNTech (BNTX) Stocks Rose Over Vaccine Authorization, Boeing (BA), American Airline (AAL) Stocks Surged After 737-Max Flight


Pfizer Inc (PFE) was up 3.53% at $40.80 while BioNTech SE (BNTX) rose by 6.21% to $121.09 on Wednesday. The United Kingdom is the first nation in the world to authorize an American and its German partner to use the Covid-19 vaccine. The vaccine will be available nationwide beginning next week as promised by the UK government. The local Medicines and Healthcare Products Regulatory Agency (MHRA) has validated the use of the vaccine. According to UK Health Minister Matt Hancock, it is the first “very good news” of authorizing a vaccine against the latest coronavirus. Pfizer claims it is possible to produce the first doses instantly and says it is an achievement in the fight against the pandemic.

Pfizer has also lodged a request with the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) as it has developed Covid-19 vaccine candidate with German BioNTech for marketing in the United States. Finally, on Monday, Pfizer/BioNTech sent an application for authorization to the European Medicines Agency for this vaccine against Covid-19.

The Boeing Company (BA) rose 5.09 percent to $223.85 and American Airlines Group Inc (AAL) surged 4.13 percent to $14.86. The companies on Wednesday organized the first public demo flight of the 737 MAX since its stop was lifted by the air transport authorities.

Another big airline listed on Wall Street, Jetblue Airways Corporation (JBLU) fell -2.92 percent to $14.97 after reporting the start of a capital raise aimed at raising just over $500 million at a price 6.6 percent lower than the closing price yesterday.

Micron Technology Inc (MU) rose 3.03 percent to $69.11. Several local analysts, following the improvement in financial guidance announced by the group for the current quarter, have lifted their target price of the stock. The company remained successful to surpass analysts’ estimates for the second quarter in a row.


Please enter your comment!
Please enter your name here